感应基因医药(RGDX)

0.2688 %

简介:Response遗传科学有限公司作为生物类的有限公司,于1999年9月23日在特拉华州成立。公司是一家生命科学类的公司,从事研究与研发癌症的临床诊断实验。公司旨在提供个人的基因信息来帮助主治医师和患者选择对患者最佳的治疗方案。公司的专利技术能从福尔马林石蜡包埋(简称FFPE)中存储的肿瘤细胞样本可靠连贯地提取核糖核酸与脱氧核糖核酸,从而分析这些组织中的基因信息。公司的技术也能利用FFPE患者的活组织切片检查深入地诊断和测试。


公司网站:
公司地址:1640 Marengo St. 7th Floor Los Angeles California 90033
公司电话:1-323-2243900
今开:昨收:0.2688
最高:最低:
涨停价:跌停价:
总市值:10428202

感应基因医药的热门讨论

感应基因医药的最新讨论

感应基因医药的公告

公告

$感应基因医药(RGDX)$ 8-K - Current report Filed: 2015-10-14 AccNo: 0001144204-15-059264 Size: 18 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compe...

公告

$感应基因医药(RGDX)$ 8-K - Current report Filed: 2015-08-26 AccNo: 0001144204-15-051841 Size: 13 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接

公告

$感应基因医药(RGDX)$ 8-K - Current report Filed: 2015-08-11 AccNo: 0001144204-15-048074 Size: 476 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.03: Bankruptcy or ReceivershipItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Bal...

公告

$感应基因医药(RGDX)$ 8-K - Current report Filed: 2015-07-06 AccNo: 0001144204-15-041012 Size: 14 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接

公告

$感应基因医药(RGDX)$ 8-K - Current report Filed: 2015-07-01 AccNo: 0001144204-15-040386 Size: 74 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant...